CA2918576A1 - Compositions de combinaison d'analgesique et antiemetique a liberation immediate - Google Patents
Compositions de combinaison d'analgesique et antiemetique a liberation immediate Download PDFInfo
- Publication number
- CA2918576A1 CA2918576A1 CA2918576A CA2918576A CA2918576A1 CA 2918576 A1 CA2918576 A1 CA 2918576A1 CA 2918576 A CA2918576 A CA 2918576A CA 2918576 A CA2918576 A CA 2918576A CA 2918576 A1 CA2918576 A1 CA 2918576A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- opioid analgesic
- agent
- release
- promethazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85045106P | 2006-10-09 | 2006-10-09 | |
US60/850,451 | 2006-10-09 | ||
US95256307P | 2007-04-03 | 2007-04-03 | |
US60/952,563 | 2007-04-03 | ||
US94837507P | 2007-07-06 | 2007-07-06 | |
US60/948,375 | 2007-07-06 | ||
CA2665841A CA2665841C (fr) | 2006-10-09 | 2007-10-09 | Compositions pharmaceutiques |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2665841A Division CA2665841C (fr) | 2006-10-09 | 2007-10-09 | Compositions pharmaceutiques |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2918576A1 true CA2918576A1 (fr) | 2008-06-12 |
CA2918576C CA2918576C (fr) | 2019-01-08 |
Family
ID=39492908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2918576A Active CA2918576C (fr) | 2006-10-09 | 2007-10-09 | Compositions de combinaison d'analgesique et antiemetique a liberation immediate |
Country Status (3)
Country | Link |
---|---|
CA (1) | CA2918576C (fr) |
PT (1) | PT2124556E (fr) |
WO (1) | WO2008070268A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2665841C (fr) | 2006-10-09 | 2016-04-05 | Charleston Laboratories, Inc. | Compositions pharmaceutiques |
JP5714910B2 (ja) | 2008-01-09 | 2015-05-07 | チャールストン ラボラトリーズ,インコーポレイテッド | 薬学的組成物 |
EP2184276A1 (fr) | 2008-11-07 | 2010-05-12 | Universite Paul Cezanne Aix-Marseille Iii | Procédé de préparation de nouvelles 1H-benzo(d) imidazol-2(3h)-ones substituées, de nouveaux intermédiaires et leur utilisation en tant qu'inhibiteurs de bace 1 |
CN102307895A (zh) * | 2008-12-04 | 2012-01-04 | 里兰斯坦福初级大学理事会 | 用于治疗或预防麻醉药停药症状的方法和组合物 |
WO2011006012A1 (fr) | 2009-07-08 | 2011-01-13 | Charleston Laboratories Inc. | Compositions pharmaceutiques |
WO2011063164A2 (fr) * | 2009-11-18 | 2011-05-26 | Steady Sleep Rx Co., Inc. | Médicaments de cannabinoïde à libération prolongée |
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
WO2015095391A1 (fr) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Comprimé extrudé anti-abus à libération prolongée |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015157509A1 (fr) * | 2014-04-10 | 2015-10-15 | The Trustees Of The University Of Pennsylvania | Compositions et methodes de traitement de maladies associées aux recepteurs des opioides |
CA2945355A1 (fr) * | 2014-04-10 | 2015-10-15 | Charleston Laboratories, Inc. | Compositions pharmaceutiques |
CA2955229C (fr) | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Forme posologique remplie de liquide anti-abus a liberation immediate |
EP3209282A4 (fr) | 2014-10-20 | 2018-05-23 | Pharmaceutical Manufacturing Research Services, Inc. | Forme galénique anti-abus de remplissage de liquide à libération prolongée |
WO2017066488A1 (fr) * | 2015-10-13 | 2017-04-20 | Charleston Laboratories, Inc. | Traitement de la douleur à l'aide d'une composition comprenant un opioïde et un antiémétique |
EP3423041A4 (fr) | 2016-03-04 | 2019-09-11 | Charleston Laboratories, Inc. | Compositions pharmaceutiques |
CA3066113A1 (fr) * | 2016-06-10 | 2017-12-14 | Charleston Laboratories, Inc. | Compositions pharmaceutiques comprenant un analgesique opioide et un antiemetique pour traiter la douleur |
JP2023534810A (ja) | 2020-07-15 | 2023-08-14 | シャバー リサーチ アソシエイツ エルエルシー | 急性痛の処置並びに胸やけの重症度及び/又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物 |
US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4113866A (en) * | 1977-04-01 | 1978-09-12 | The Upjohn Company | Analgetic compounds, compositions and process of treatment |
US5055461A (en) * | 1989-02-15 | 1991-10-08 | Richardson-Vicks Inc. | Anesthetic oral compositions and methods of use |
IT1255522B (it) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
-
2007
- 2007-10-09 PT PT78711397T patent/PT2124556E/pt unknown
- 2007-10-09 WO PCT/US2007/080831 patent/WO2008070268A2/fr active Application Filing
- 2007-10-09 CA CA2918576A patent/CA2918576C/fr active Active
Also Published As
Publication number | Publication date |
---|---|
WO2008070268A3 (fr) | 2008-11-27 |
WO2008070268A2 (fr) | 2008-06-12 |
PT2124556E (pt) | 2014-12-03 |
CA2918576C (fr) | 2019-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220062276A1 (en) | Pharmaceutical compositions | |
CA2918576C (fr) | Compositions de combinaison d'analgesique et antiemetique a liberation immediate | |
US9789105B2 (en) | Pharmaceutical compositions | |
CA2767576C (fr) | Compositions pharmaceutiques refermant un antiemetique et un analgesiqueopioide | |
EP3129028A1 (fr) | Compositions pharmaceutiques | |
WO2017066488A1 (fr) | Traitement de la douleur à l'aide d'une composition comprenant un opioïde et un antiémétique | |
DK2124556T3 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20160122 |